Physician profile
Hannah Dolloff
NPI 1265238885
$451.85
in general payments reported to CMS, 2019-2025
14 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $74.49 | 2025 | |
| Lundbeck LLC | $49.48 | 2025 | Rexulti |
| Inspire Medical Systems, INC. | $46.63 | 2025 | Inspire |
| Janssen Pharmaceuticals, INC | $39.97 | 2025 | Spravato |
| Biogen, INC. | $38.45 | 2025 | Zurzuvae |
| Antares Pharma, INC. | $30.43 | 2025 | Xyosted |
| Takeda Pharmaceuticals U.S.A., INC. | $29.98 | 2025 | Trintellix |
| Sanofi-Aventis U.S. LLC | $25.80 | 2025 | |
| Phathom Pharmaceuticals, INC. | $25.78 | 2025 | Voquezna |
| Xeris Pharmaceuticals, INC. | $19.49 | 2025 | Recorlev |
| Novo Nordisk INC | $19.10 | 2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $18.38 | 2025 | |
| Lilly USA, LLC | $17.83 | 2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $16.04 | 2025 | Breztri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Dolloff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.